|Biotech Due Diligence||
Please enjoy the latest edition of the BiotechDueDIligence Journal Watch - a round-up of articles from the scientific and medical literature that are related to, or are driving, biopharma discussion. This week's collections is a hybrid of some links I have curated plus a couple from the Twitter stream.
We had a bit of everything this week: data euphoria, data ridicule, blue skies, bubble talk and much more. Catch up on the action with the latest edition of the Biotech Tweets of the Week. Thanks as always to @23aloha for helping to curate this feature.
$BIIB $VRTX $GILD $MEIP $ESPR $PTCT $ACAD $CNAT $TRIL $KITE $JUNO $GNFT $ICPT $BMRN and many more! $XBI $IBB
Trial Results Seldom Posted to Clinicaltrials.gov as Required
Sarah Wickline Wallan (Medpage Today)
Finding Success In Failing Early: All About Execution
Ankit Mahadevia (LifeSciVC)
Amgen Releases A Giant Genetic Portrait Of A Nation -- And A Map Of The Future
Matthew Herper (Forbes) $AMGN
Is slack science reporting letting down the public?
Lucy Ward (The Guardian)
What's That Stuff? Magic Sand And Kinetic Sand
Andrea Widener (C&E News)
New Research Shows We May Be Looking at Alzheimer's All Wrong
Cynthia Koons (Bloomberg) $BIIB $ABBV $JNJ $LLY $ROG
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?
Ben Fidler (Xconomy) $BAX $ALNY $BMRN $QURE $BIIB $SGMO
Our apologies for being a bit late with this weeks Biotech Tweets of the Week, but on the plus side we were better able to capture the crazy Friday headlined by the early morning $BIIB BIIB037 Alzheimer's Disease data, exuberance, discussion and dissection. Thanks as always to @23aloha for curating this feature.
$SLXP $AMGN $REGN $ESPR $GILD $RTRX $BIIB $ACAD $TRIL $PRTA $ICPT $CNDO and more $XBI $IBB
What happens when you combine two of the most popular features here at BiotechDueDiligence - Tweets of the Week and Journal Watch? You get a Twitter-sourced collection of intriguing and noteworthy articles from scientific and medical journals. I've been meaning to try this for awhile, so let me know what you think!